eBooks Press Release — NEWS |The Seventh Volume of Frontiers in Clinical Drug Research – Alzheimer Disorders Covers Critical Discussions on AD Biochemistry & New Therapies

This book is by Dr. Atta-Ur-Rahman, Published on: November 2, 2018.

 

 

Frontiers in Clinical Drug Research – Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in the field of Alzheimer’s disease research..

The seventh volume of this series features chapters covering critical discussions on AD biochemistry and new therapies. The reviews in this volume include:

The fourth volume of the series brings seven reviews covering these topics:

  • Deep Brain Stimulation in the Treatment of Alzheimer’s disease
  • ASS234: A New and Promising Anti-Alzheimer Agent
  • Recent Advances in Alzheimer’s Drug Discovery Research
  • Alzheimer’s Disease and Proteasome: The Therapeutic Development and Management
  • Alzheimer´s Disease: Fundamental Concepts, Novel Findings and Therapeutics Outcomes Coming from the Ca2+/cAMP Signalling Interaction
  • Alzheimer’s Disease: An Approach for Non-Pharmacological Therapies
  • Past and Present Drug Development for Alzheimer’s Disease

About the Author:

Atta-ur-Rahman, Ph.D. in organic chemistry from Cambridge University (1968), has 1080 international publications in several fields of organic chemistry including 751 research publications, 37 international patents, 69 chapters in books and 221 books published largely by major U.S. and European presses. He is the Editor-in-Chief of eight European Chemistry journals. He is Editor of the world’s leading encyclopedic series of volumes on natural products, Studies in Natural Product Chemistry, 54 volumes of which have been published under his Editorship by Elsevier during the last two decades.

Keywords: Alzheimer’s disease, Deep brain stimulation, ASS234, drug discovery, Alzheimer’s Disease and Proteasome, Non-Pharmacological Therapies, Deug development, neurodegenerative disorders, Brain neuromodulation, Hippocampus, Wnt signaling pathway.

 

To view full eBook, please visit: https://ebooks.benthamscience.com/book/9781681085609/

Bentham News

Bentham Science Press Release

Bentham Science Publishers is pleased to announce the launch of a number of  journals on the ScholarOne Manuscript site. Through this new electronic dashboard manuscripts  can be conveniently submitted, reviewed and their status checked.

Access the below mentioned links for submission:

Current Alzheimer Research         http://mc04.manuscriptcentral.com/cares
Current Medicinal Chemistry         http://mc04.manuscriptcentral.com/crmc
Current Drug Metabolism             http://mc04.manuscriptcentral.com/cdm
Current Pharmaceutical Biotechnology         http://mc04.manuscriptcentral.com/cpb
Current Molecular Medicine         http://mc04.manuscriptcentral.com/crmm
Current Neuropharmacology         http://mc04.manuscriptcentral.com/crn
Current Genomics                 http://mc04.manuscriptcentral.com/crg

Bentham Science Publishers to preserve e-journals with Portico

News release date: October 31, 2014

We are pleased to announce that Bentham Science Publishers will be preserving its e-journals with Portico, ensuring that their content will be secure and available into the future. Bentham Science Publishers is based in Sharjah, United Arab Emirates. [BSP102014]

Bentham Science Publishers is a publishing company of scientific, technical, and medical literature based at Sharjah. Bentham publishes more than 130 subscription-based academic journals across fields of science, technology, and medicine.

%d bloggers like this: